rTMS efficacy varies by individual rather than by condition

In patients with two neuropsychiatric conditions, such as neuropathic pain and depression, repeated transcutaneous magnetic stimulation (rTMS) is most likely to be effective in both conditions or not at all. Professor Satu Jääskeläinen presenting at NeuPSIG 2019 suggested that these data may be indicative of an underlying genetic susceptibility to the therapy.